© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SRSCV2 BVL 25MCG/.25ML 2 | Medium Descr | A IMM ADMN SARSCOV2 BIVALENT 25 MCG/0.25 ML 2ND | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage; second dose | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Not Discounted when Multiple | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2024-01-01 | Added | First appearance in Codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-04-18 | Added | Addition released to AMA website on 2023-05-01. Retroactive to 2023-04-18. |
| 2023-04-18 | Note | AMA guideline includes 91301, 91306, 91309, 91311, 91313, 91316, 0144A: Published to website & received FDA approval prior to the addition of 0142A. |
| 2023-04-18 | Note | AMA guideline changed to include 0141A; published to website 2023-05-01. Received FDA approval retroactively to 2023-04-18. |
| 2023-04-18 | Note | These codes (associated with 0142A) are no longer authorized for use in the United States: 91301, 91306 91309, 91311. |